Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 49

1.

MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PA, Gardner BK, Behbahan IS, Horvath S, Chia D, Mellinghoff IK, Hurvitz SA, Dubinett SM, Critchlow SE, Kurdistani SK, Goodglick L, Braas D, Graeber TG, Christofk HR.

Cell Rep. 2016 Feb 23;14(7):1590-601. doi: 10.1016/j.celrep.2016.01.057. Epub 2016 Feb 11.

2.

High expression of AGR2 in lung cancer is predictive of poor survival.

Alavi M, Mah V, Maresh EL, Bagryanova L, Horvath S, Chia D, Goodglick L, Liu AY.

BMC Cancer. 2015 Oct 6;15:655. doi: 10.1186/s12885-015-1658-2.

3.

Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status.

Mah V, Alavi M, Márquez-Garbán DC, Maresh EL, Kim SR, Horvath S, Bagryanova L, Huerta-Yepez S, Chia D, Pietras R, Goodglick L.

PLoS One. 2015 May 22;10(5):e0127600. doi: 10.1371/journal.pone.0127600. eCollection 2015.

4.

The cerebellum ages slowly according to the epigenetic clock.

Horvath S, Mah V, Lu AT, Woo JS, Choi OW, Jasinska AJ, Riancho JA, Tung S, Coles NS, Braun J, Vinters HV, Coles LS.

Aging (Albany NY). 2015 May;7(5):294-306.

5.

Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.

Hamilton N, Márquez-Garbán D, Mah V, Fernando G, Elshimali Y, Garbán H, Elashoff D, Vadgama J, Goodglick L, Pietras R.

Biomed Res Int. 2015;2015:925703. doi: 10.1155/2015/925703. Epub 2015 Mar 22.

6.

Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Hamilton N, Marquez-Garban D, Mah VH, Elshimali Y, Elashoff D, Garon EB, Vadgama J, Pietras R.

Crit Rev Oncog. 2015;20(5-6):373-90. doi: 10.1615/CritRevOncog.v20.i5-6.100.

PMID:
27279236
7.

Non-Small Cell Lung Cancers in Women and Men: Differences in Biology, Behavior, and Outcomes.

Mah VH.

Crit Rev Oncog. 2015;20(5-6):349-55. doi: 10.1615/CritRevOncog.v20.i5-6.80.

PMID:
27279234
8.

SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.

Sun QY, Ding LW, Xiao JF, Chien W, Lim SL, Hattori N, Goodglick L, Chia D, Mah V, Alavi M, Kim SR, Doan NB, Said JW, Loh XY, Xu L, Liu LZ, Yang H, Hayano T, Shi S, Xie D, Lin DC, Koeffler HP.

J Pathol. 2015 Mar;235(4):559-70. doi: 10.1002/path.4482. Epub 2014 Dec 18.

9.

Consulting communities when patients cannot consent: a multicenter study of community consultation for research in emergency settings.

Dickert NW, Mah VA, Biros MH, Harney DM, Silbergleit R, Sugarman J, Veledar E, Weinfurt KP, Wright DW, Pentz RD.

Crit Care Med. 2014 Feb;42(2):272-80. doi: 10.1097/CCM.0b013e3182a27759.

10.

Enrollment in research under exception from informed consent: the Patients' Experiences in Emergency Research (PEER) study.

Dickert NW, Mah VA, Baren JM, Biros MH, Govindarajan P, Pancioli A, Silbergleit R, Wright DW, Pentz RD.

Resuscitation. 2013 Oct;84(10):1416-21. doi: 10.1016/j.resuscitation.2013.04.006. Epub 2013 Apr 16.

11.

Silver(I) complex formation with cysteine, penicillamine, and glutathione.

Leung BO, Jalilehvand F, Mah V, Parvez M, Wu Q.

Inorg Chem. 2013 Apr 15;52(8):4593-602. doi: 10.1021/ic400192c. Epub 2013 Apr 4.

12.

Spotlight on middle childhood: Rejuvenating the 'forgotten years'.

Mah VK, Ford-Jones EL.

Paediatr Child Health. 2012 Feb;17(2):81-3.

13.

Prostate cancer cell phenotypes based on AGR2 and CD10 expression.

Ho ME, Quek SI, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V, Alavi M, Kim SR, Bagryanova L, Horvath S, Chia D, Goodglick L, Liu AY.

Mod Pathol. 2013 Jun;26(6):849-59. doi: 10.1038/modpathol.2012.238. Epub 2013 Jan 25.

14.

Lead(II) complex formation with glutathione.

Mah V, Jalilehvand F.

Inorg Chem. 2012 Jun 4;51(11):6285-98. doi: 10.1021/ic300496t. Epub 2012 May 17.

15.

Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer.

Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK.

Am J Physiol Lung Cell Mol Physiol. 2012 Jun 1;302(11):L1150-8. doi: 10.1152/ajplung.00384.2010. Epub 2012 Feb 17.

16.

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.

Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, Mah V, Rivera-Pazos CM, Chatterjee D, Vega MI, Maresh EL, Horvath S, Chia D, Bonavida B, Goodglick L.

BMC Cancer. 2011 Jun 21;11:259. doi: 10.1186/1471-2407-11-259.

17.

Protein expression based multimarker analysis of breast cancer samples.

Presson AP, Yoon NK, Bagryanova L, Mah V, Alavi M, Maresh EL, Rajasekaran AK, Goodglick L, Chia D, Horvath S.

BMC Cancer. 2011 Jun 8;11:230. doi: 10.1186/1471-2407-11-230.

18.

Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.

Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, Bagryanova L, Horvath S, Chia D, Garon E, Goodglick L, Pietras RJ.

Steroids. 2011 Aug;76(9):910-20. doi: 10.1016/j.steroids.2011.04.015. Epub 2011 May 8.

19.

Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Mah V, Marquez D, Alavi M, Maresh EL, Zhang L, Yoon N, Horvath S, Bagryanova L, Fishbein MC, Chia D, Pietras R, Goodglick L.

Lung Cancer. 2011 Nov;74(2):318-25. doi: 10.1016/j.lungcan.2011.03.009. Epub 2011 Apr 20.

20.

Differential expression of anterior gradient gene AGR2 in prostate cancer.

Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L.

BMC Cancer. 2010 Dec 13;10:680. doi: 10.1186/1471-2407-10-680.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk